Chinese investors acquired stake at Israeli biotech firm for $3 million
Guangxi Wuzhou Zhongheng Group, a Chinese investment holdings company, through its subsidiary has invested $3 million in Israeli biotechnology firm Integra Holdings.
Integra Holdings, founded in 2012, has a portfolio of companies operating in a variety of therapeutic areas such as oncology, Alzheimer's disease and infectious diseases. Integra Holdings has raised a total of $12 million to date.
Guangxi Wuzhou Zongheng Group is listed in the Chinese Investors Directory with the code XJO31
More details follows
Investors Directory 2022
